Relief Therapeutics Holding AG (RLFTF)

[Charliebee]

Based on these findings, aviptadil has been selected for inclusion in Operation Warp Speed, administered by the US Department of Health and Human Services. COVID-19 therapeutics will remain a top priority, no matter how promising the efforts at vaccine development become. Unlike expensive-to-produce monoclonal antibodies and difficult-to-scale convalescent plasma, VIP can ultimately be produced at a cost of pennies per dose, if moved from chemical peptide synthesis to yeast fermentation, as is done for insulin. As such, it may represent a critical therapeutic for COVID-19 and possibly other viral infections for both the developed and the developing world.